298 related articles for article (PubMed ID: 9378961)
1. The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL.
Hadley GA; Bartlett ST; Via CS; Rostapshova EA; Moainie S
J Immunol; 1997 Oct; 159(8):3748-56. PubMed ID: 9378961
[TBL] [Abstract][Full Text] [Related]
2. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells.
Wong WK; Robertson H; Carroll HP; Ali S; Kirby JA
Transplantation; 2003 Feb; 75(4):505-14. PubMed ID: 12605119
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention.
Franciszkiewicz K; Le Floc'h A; Jalil A; Vigant F; Robert T; Vergnon I; Mackiewicz A; Benihoud K; Validire P; Chouaib S; Combadière C; Mami-Chouaib F
Cancer Res; 2009 Aug; 69(15):6249-55. PubMed ID: 19638592
[TBL] [Abstract][Full Text] [Related]
4. Role of the mucosal integrin alpha(E)(CD103)beta(7) in tissue-restricted cytotoxicity.
Smyth LJ; Kirby JA; Cunningham AC
Clin Exp Immunol; 2007 Jul; 149(1):162-70. PubMed ID: 17403056
[TBL] [Abstract][Full Text] [Related]
5. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.
Webb JR; Wick DA; Nielsen JS; Tran E; Milne K; McMurtrie E; Nelson BH
Gynecol Oncol; 2010 Sep; 118(3):228-36. PubMed ID: 20541243
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
Waeckerle-Men Y; Starke A; Wüthrich RP
Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the epithelial cell-specific integrin, CD103, by human CD8+ cytolytic T lymphocytes.
Hadley GA; Rostapshova EA; Gomolka DM; Taylor BM; Bartlett ST; Drachenberg CI; Weir MR
Transplantation; 1999 Jun; 67(11):1418-25. PubMed ID: 10385079
[TBL] [Abstract][Full Text] [Related]
8. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
[TBL] [Abstract][Full Text] [Related]
9. Renal allograft rejection: the contribution of chemokines to the adhesion and retention of alphaE(CD103)beta7 integrin-expressing intratubular T cells.
Al-Hamidi A; Pekalski M; Robertson H; Ali S; Kirby JA
Mol Immunol; 2008 Sep; 45(15):4000-7. PubMed ID: 18649941
[TBL] [Abstract][Full Text] [Related]
10. CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes.
Ericsson A; Svensson M; Arya A; Agace WW
Eur J Immunol; 2004 Oct; 34(10):2720-9. PubMed ID: 15368288
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance.
Keino H; Masli S; Sasaki S; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1533-42. PubMed ID: 16565389
[TBL] [Abstract][Full Text] [Related]
12. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
[TBL] [Abstract][Full Text] [Related]
13. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice.
Schön MP; Arya A; Murphy EA; Adams CM; Strauch UG; Agace WW; Marsal J; Donohue JP; Her H; Beier DR; Olson S; Lefrancois L; Brenner MB; Grusby MJ; Parker CM
J Immunol; 1999 Jun; 162(11):6641-9. PubMed ID: 10352281
[TBL] [Abstract][Full Text] [Related]
14. Predominant donor CD103+CD8+ T cell infiltration into the gut epithelium during acute GvHD: a role of gut lymph nodes.
Zhou S; Ueta H; Xu XD; Shi C; Matsuno K
Int Immunol; 2008 Mar; 20(3):385-94. PubMed ID: 18303011
[TBL] [Abstract][Full Text] [Related]
15. Alloantigen-induced regulatory CD8+CD103+ T cells.
Koch SD; Uss E; van Lier RA; ten Berge IJ
Hum Immunol; 2008 Nov; 69(11):737-44. PubMed ID: 18822329
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CD103 expression by CD8+ T cells responding to renal allografts.
Wang D; Yuan R; Feng Y; El-Asady R; Farber DL; Gress RE; Lucas PJ; Hadley GA
J Immunol; 2004 Jan; 172(1):214-21. PubMed ID: 14688328
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin enhances the number of alloantigen-induced human CD103+CD8+ regulatory T cells in vitro.
Uss E; Yong SL; Hooibrink B; van Lier RA; ten Berge IJ
Transplantation; 2007 Apr; 83(8):1098-106. PubMed ID: 17452901
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
19. CD103+ CTL accumulate within the graft epithelium during clinical renal allograft rejection.
Hadley GA; Charandee C; Weir MR; Wang D; Bartlett ST; Drachenberg CB
Transplantation; 2001 Nov; 72(9):1548-55. PubMed ID: 11707744
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of interleukin 12 and interleukin 10 on superantigen-induced expression of cutaneous lymphocyte-associated antigen (CLA) and alphaEbeta7 integrin (CD103) by CD8+ T cells.
Sigmundsdóttir H; Johnston A; Gudjónsson JE; Valdimarsson H
Clin Immunol; 2004 Apr; 111(1):119-25. PubMed ID: 15093560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
